Contentious Issues in Gout Management: The Story so Far
Mohamed Talaat1, Kyle Park1, Naomi Schlesinger2
1Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Insights
Gout management requires viewing it as a chronic disease, not just acute flares. Effective treatment involves chronic urate-lowering therapy and anti-inflammatory prophylaxis to manage gout long-term.
Area of Science:
- Rheumatology
- Internal Medicine
Background:
- Gout is the most prevalent inflammatory arthritis globally.
- Despite its long history, gout management faces persistent challenges.
- A common misconception views gout solely as an acute condition requiring episodic treatment.
Purpose of the Study:
- To address contentious issues in current gout management strategies.
- To emphasize the necessity of chronic disease management for gout.
- To highlight the importance of urate-lowering therapy and prophylaxis.
Main Methods:
- Discussion of contentious issues in gout management.
- Review of chronic urate-lowering therapy principles.
- Consideration of anti-inflammatory prophylaxis during therapy initiation.
Main Results:
- Chronic urate-lowering therapy is crucial for long-term gout control.
- Reducing serum urate levels below 6.8 mg/dL is a key target.
- Prophylaxis is essential when initiating urate-lowering treatments.
Conclusions:
- Gout must be managed as a chronic illness, not just acute flares.
- Chronic urate-lowering therapy and prophylaxis are vital for effective gout control.
- Addressing contentious issues can improve patient outcomes and guide treatment decisions.
Abstract:
Gout is the most common inflammatory arthritis worldwide. Although gout has been known for antiquity, many challenges still exist in gout management. It is vital to view gout as a chronic disease and not just treat the acute flare. There is a perception of gout as an acute disease requiring treatment only for acute flares. However, to combat the disease, chronic urate-lowering therapy, reducing the serum urate levels to below the saturation threshold of 6.8 mg/dL, and chronic anti-inflammatory prophylaxis, especially during urate-lowering therapy initiation, are needed. In this manuscript, we discuss some of the contentious issues in gout management. These include the timing of urate-lowering therapy initiation, which urate-lowering therapy to chose, should comorbidities influence our treatment, using genetic determinants, and patient perspectives to drive treatment and differences between gout treatment the American College of Physicians and Rheumatology guidelines for gout management: driving care.
Related Concept Videos
01:30Urinary Tract Calculi III: Medical Management
01:23Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:30Acute Pancreatitis II: Clinical Manifestations and Management
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
01:28Urinary Tract Calculi V: Nursing Management
01:27Urinary Tract Calculi IV: Nutrition Therapy and Prevention